Fragile X Syndrome and Targeted Treatments
Many targeted treatment studies have been carried out in individuals with Fragile X Syndrome (FXS) guided by animal studies from the Fragile X Mental Retardation 1 (FMR1) knock out (KO) mice and the fragile X Drosophila studies. Here we review the many medications that have been studied in patients...
Saved in:
| Main Authors: | Nattaporn Tassanakijpanich, Ana María Cabal-Herrera, Maria Jimena Salcedo-Arellano, Randi Jenssen Hagerman |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Diponegoro University
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e75efb3b52fc469bbf4c4b7a35bd2cbe |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal Mental Health and Parenting Stress and Their Relationships to Characteristics of the Child With Fragile X Syndrome
by: Lauren Bullard, et al.
Published: (2021) -
Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
by: Scott Thomas, et al.
Published: (2021) -
The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
by: Alice Romagnoli, et al.
Published: (2021) -
Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
by: Cedrik Tekendo-Ngongang, et al.
Published: (2021) -
Síndrome del X-Frágil: Discusión del Primer Caso confirmado citogenéticamente en Chile
by: Lacassle S,Yves, et al.
Published: (1983)